Barrie, ON, and Quebec, QC – January 16, 2025 – Southmedic Incorporated (Barrie, ON), a leader in innovative medical devices, and OxyNov (Quebec, QC), renowned for its advanced oxygen therapy solutions, are pleased to announce an exclusive partnership. This collaboration brings together the flagship technologies of Southmedic’s Oxy2Mask™ and OxyNov’s FreeO2™ system, offering the safest, most cost-effective, and labour-efficient solution for oxygen delivery to patients across Canada.
The Oxy2Mask™, recognized for its revolutionary open design, provides unparalleled oxygen delivery across a wide range of flow rates (1 LPM to 15+ LPM) and enhances patient safety, while ensuring exceptional patient comfort and compliance. Its unique design allows for reduced rebreathing of CO2 at any flow rate and effective titration of oxygen while enabling natural communication, reducing claustrophobia, and improving overall patient experience.
OxyNov’s FreeO2™ system is an automated oxygen titration technology that continuously monitors and adjusts oxygen flow in real-time based on a patient’s oxygen saturation levels. By automating this critical process, FreeO2™ reduces the workload for healthcare professionals, optimizes oxygen therapy, and enhances patient safety by minimizing risks of over- or under-oxygenation.
Combining the Oxy2Mask™ with the FreeO2™ system represents a transformative step in oxygen therapy delivery. Together, these technologies ensure:
- Enhanced Patient Safety: Real-time, automated titration with FreeO2™ paired with Oxy2Mask’s precision and flexibility minimizes oxygen-related complications.
- Labour Efficiency: Reduced clinician workload through automated oxygen management using one oxygen device with a broad FiO2 delivery range, allowing staff to focus on other critical patient care needs.
- Cost Effectiveness: Optimized oxygen usage and streamlined processes result in significant cost savings for healthcare institutions.
- Unmatched Comfort and Compliance: Oxy2Mask’s patient-centric design supports a cooler, more comfortable patient experience that includes unhindered communication, drinking, and administration of oral meds without interruption of oxygen delivery, while FreeO2™ seamlessly adapts oxygen delivery to patient needs, giving the patient precisely the amount of oxygen they need, when they need it.
“This partnership is a natural next step as we integrate two leading technologies that perfectly complement one another,” said Lee McDonald CEO at Southmedic. “By combining the precision and adaptability of Oxy2Mask™ with the intelligence of the FreeO2™ system, we are advancing oxygen therapy to improve both patient outcomes and healthcare efficiencies.”
Patrice Allibert, CEO at OxyNov, added, “Our collaboration with Southmedic aligns with our shared commitment to innovation and patient safety. Together, we are providing healthcare professionals with a streamlined solution that enhances care delivery and optimizes resources.”
This exclusive partnership between Southmedic and OxyNov reflects both companies’ dedication to delivering state-of-the-art solutions that address the evolving needs of Canadian healthcare providers and their patients.
About OxyNov
Headquartered in Quebec, QC, OxyNov specializes in advanced automated oxygen therapy solutions. The FreeO2™ system has redefined how oxygen therapy is delivered, ensuring precision, safety, and efficiency in patient care.